HHSN26100010 task order title: preclinical studies to evaluate the combination of metformin and aspirin for the prevention of pancreatic cancer. Period of performance: september 16, 2014 through…
Ended Awarded Last action
- Contract number
- HHSN26100010
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $530,786
Award facts
- Opportunity
-
- N01CN2500278 Solicitation number
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Feb 27, 2012
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Dec 15, 2011
- Contract value 100% obligated
- $530,785.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$103 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $530,889 |
Description
HHSN26100010 task order title: preclinical studies to evaluate the combination of metformin and aspirin for the prevention of pancreatic cancer. Period of performance: september 16, 2014 through september 15, 2016
Quick answers
Who was awarded contract HHSN26100010?
HHSN26100010 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 16, 2014.
How much is contract HHSN26100010 worth?
The government has obligated $530,786 on HHSN26100010.
Is contract HHSN26100010 an order under another contract?
Yes. HHSN26100010 is a delivery order under HHSN261201200013I, an indefinite delivery contract, on Preclinical Efficacy and Intermediate Endpoint Biomarkers.
Was contract HHSN26100010 competed?
The extent of competition for HHSN26100010 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award